1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. Canada >
  5. Quebec >
  6. Therachon AG Acquires GLyPharma Therapeutic

M&A Deal Summary

Therachon AG Acquires GLyPharma Therapeutic

On October 9, 2018, Therachon AG acquired life science company GLyPharma Therapeutic

Acquisition Highlights
  • This is Therachon AG’s 1st transaction in the Life Science sector.
  • This is Therachon AG’s 1st transaction in Canada.
  • This is Therachon AG’s 1st transaction in Quebec.

M&A Deal Summary
Date 2018-10-09
Target GLyPharma Therapeutic
Sector Life Science
Buyer(s) Therachon AG
Deal Type Add-on Acquisition

Target

GLyPharma Therapeutic

Montreal, Quebec, Canada
GLyPharma Therapeutic, Inc. is a pharmaceutical company specialized in the discovery and development of active peptides, FONDS de solidarité FTQ and CTI Life Sciences Fund. GLyPharma Therapeutic, Inc. was founded in 2012 and is based in Montreal, Quebec.

Search 214,239 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Therachon AG

Basel, Switzerland
Category Company
Founded 2014
Sector Life Science
DESCRIPTION

Therachon AG is a clinical-stage global biotechnology company focused on the discovery and development of innovative treatment for severe, rare conditions with significant unmet need. Therachon AG was founded in 2014 and is based in Basel, Switzerland.

DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
State: Quebec M&A 1 of 1
Country: Canada M&A 1 of 1
Year: 2018 M&A 1 of 1
Mergr

Solution for

Product

Company

Legal